Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep427 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Insulin autoimmune syndrome-a case report

Alaguney Elif Sevil , Efe Belgin , Yorulmaz Goknur , Acu Berat , Durmus Insaf

Introduction: Hypoglycemia is a medical emergency that can have many different causes in etiology. Autoimmune hypoglycemia in patients with very high insulin levels should also be considered in the differential diagnosis.Case: A 50-year-old man was admitted to our clinic for investigation and treatment of hypoglycemic episodes. He did not have any evidence for the use of oral antidiabetic medications, insulin, herbal substances. However, in our history, ...

ea0014p538 | (1) | ECE2007

Increased intraovarian levels of noradrenaline and NGF precede the follicular changes in the rat ovary at the end of reproductive period

Paredes Alfonso H , Acuña Eric , Fornes Romina , Lara Hernan E

Reports in the literature have demonstrated an increased number of nerve fibers and the presence of a follicle development similar to polycystic ovary during perimenopausal ovary in women. Since differentiation, proliferation and growth of nerves depends of nerve growth factor (NGF), changes in the content of nerves fiber could be preceded by increases in NGF and p75 neurotrophin receptor (p75NTR). Our purpose was to evaluate the changes in noradrenaline (NA) at the celiac gan...

ea0070aep625 | Pituitary and Neuroendocrinology | ECE2020

Malignant insulinoma treated with 177Lu-DOTATATE: Results in the first year post-therapy

Concepción Terroba-Larumbe María , Maria Palacio-Mures Jose , Crespo-Soto Cristina , Perez-Saborido Baltasar , Crespo-Herrero Guillermo , Ventosa-Viña Marta , Acuña-Garcia Manuel , Alejo-Ramos Mirian , Anacabe-Goyogana Itziar , Cuellar-Olmedo Luis

Introduction: Neuroendocrine tumors (NETs) are rare and their clinical behavior and prognosis correlates with mitotic rate and Ki-67 index. Most patients with advanced NET have liver metastases unresectable and somatostatin analogues are the initial therapy of choice but when disease progresses despite treatment and there are positive somatostatin receptors, peptide receptor radioligand therapy (PRRT), using lutetium-177, is a therapeutic option.Clinical...

ea0070ep372 | Pituitary and Neuroendocrinology | ECE2020

Pasireotide therapy in a patient with pituitary macroadenoma and asymptomatic acromegaly resistant to first generation somatostatin analogues

Concepción Terroba-Larumbe María , Palacio-Mures Jose Maria , Crespo-Soto Cristina , Ventosa-Viña Marta , Cuellar-Olmedo Luis , Acuña-Garcia Manuel , Anacabe-Goyogana Itziar , Areli Ticona-Spinoza Danay , Maria Delgado-Sanz Jose , Angel Rodriguez Garcia Javier

Introduction: Acromegaly increases morbidity and mortality and should be treated even in the asymptomatic phase. It is almost always caused by a GH-producing pituitary adenoma and although transsphenoidal surgery is the treatment of choice in most cases, in others, primary medical therapy is indicated.Clinical case: A 36-year-old female with a family history of thyroid functional pathology and diagnosed with micronodular goiter was evaluated in February ...